Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Predictive Factors for Ruptures of Meije Duo ™ Size 1 and 2 Femoral Stems in Hip Replacement Surgery

NCT04262713 is registered in ClinicalTrials.gov with Groupe Hospitalier Diaconesses Croix Saint-Simon as lead sponsor.

NCT NCT04262713
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04262713 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Predictive Factors for Ruptures of Meije Duo ™ Size 1 and 2 Femoral Stems in Hip Replacement Surgery
Lead sponsor
Groupe Hospitalier Diaconesses Croix Saint-Simon
Phase
Not applicable
Overall status
Completed
Start date
March 23, 2019
Completion date
April 11, 2022
Enrollment
256 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hip arthropathy associated with other conditions